Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BALAXI PHARMA Fact Sheet   (BLPH)


Potential 1000% Gains: 3 Stocks at The Heart of The Big India Revival


Here is the latest financial fact sheet of BALAXI PHARMA. For more details, see the BALAXI PHARMA quarterly results and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

BALAXI PHARMA Price History

Price Rs 610.0
Mkt Cap Rs m 6,100
Vol '000 2.9
P/E X 11.9
P/CF X 12.7
EPS (TTM) Rs 51.1
1 Day % -0.2
No. of shares m 10.00
1 Week % 6.1
1 Month % 16.3
1 Year % 6.1
52 week H/L Rs 706.0/303.6
As on Oct 3, 2022 1:49:37 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BALAXI PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
BALAXI PHARMA EQUITY SHARE DATA
High RsNANANANA702 
Low RsNANANANA342 
Sales per share (Unadj.) Rs044.745.6231.3279.4 
Earnings per share (Unadj.) Rs-2.56.56.138.147.7 
Diluted earnings per shareRs-0.82.06.138.147.7 
Cash flow per share (Unadj.) Rs-2.56.56.138.448.2 
Dividends per share (Unadj.) Rs00000.50 
Adj. dividends per shareRs0.000.000.000.000.50 
Avg Dividend yield %00000.1 
Book value per share (Unadj.) Rs5.111.627.765.0113.2 
Adj. book value per shareRs1.63.527.765.0113.2 
Shares outstanding (eoy) m3.043.0410.0010.0010.00 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x00001.9 
Avg P/E ratio x000010.9 
P/CF ratio (eoy) x000010.8 
Price / Book Value ratio x00004.6 
Dividend payout %00001.0 
Avg Mkt Cap Rs m00005,218 
No. of employees `000NANANANANA 
Total wages/salary Rs m292185125 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BALAXI PHARMA INCOME DATA
Net Sales Rs m01364562,3132,794 
Other income Rs m0962250 
Total revenues Rs m01454622,3362,844 
Gross profit Rs m-81683427508 
Depreciation Rs m00035 
Interest Rs m00038 
Profit before tax Rs m-82488443545 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m05276269 
Profit after tax Rs m-82061381477 
Gross profit margin %011.518.118.418.2 
Effective tax rate %019.430.614.012.6 
Net profit margin %014.513.416.517.1 
BALAXI PHARMA BALANCE SHEET DATA
Current assets Rs m16583499381,410 
Current liabilities Rs m12682347633 
Net working cap to sales %023.558.425.527.8 
Current ratio x12.52.24.22.72.2 
Inventory Days Days09758 
Debtors Days Days0146,9642,3771,211374 
Net fixed assets Rs m031159355 
Share capital Rs m3030100100100 
"Free" reserves Rs m-1551775501,032 
Net worth Rs m16352776501,132 
Long term debt Rs m00000 
Total assets Rs m17613609971,765 
Interest coverage x01,221.0184.2160.572.6 
Debt to equity ratio x00000 
Sales to assets ratio x02.21.32.31.6 
Return on assets %-45.632.217.138.527.4 
Return on equity %-49.555.822.058.742.1 
Return on capital %-49.569.331.968.648.9 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m01364568691,000 
Fx outflow Rs m001011087 
Net fx Rs m0136447759913 
BALAXI PHARMA CASH FLOW
From Operations Rs m -7 -15 -140 0 341 
From Investments Rs m -0 -0 -2 -60 -284 
From Financial Activity Rs m 0 0 181 36 -2 
Net Cashflow Rs m -7 -15 39 -23 55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 72.9%
Institution 19.0%
Non-Institution 8.1%
Total 100.0%
Free Float 27.1%
Pledged promoter holdings 0.0%
Shareholding as on Jun 2022
 

Company Information

Regd Off Plot No.409 2rd Floor H No 8-2-293, Maps Towers Jubilee Hills, Road No:81, Hyderabad - 500096
E-mail info@balaxipharma.in Web www.balaxipharma.in
Tel 040 23555300 Fax
Sector TRADING Group Private sector
Tr Agent Aarthi Consultants Pvt Ltd, 1-2-285, Domalaguda
CHM: Ashish Maheshwari COMP SEC: Nidhin Jose YEAR OF INC: 1942 NSE CODE: 911309 FV (Rs): 10 DIV YIELD (%): 0.1

More Trading Company Fact Sheets:   LUPIN    PIRAMAL ENTERPRISES    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    

Compare BALAXI PHARMA With:   LUPIN    PIRAMAL ENTERPRISES    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    




Today's Market

Sensex Tumbles 500 Points, Nifty Below 17,000; Hindalco, Kotak Mahindra Bank & Maruti Suzuki Top Losers(10:30 am)

Asian share markets opened lower today, extending falls on Wall Street, where fears grew that monetary tightening could lead to a global recession.